Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Oxidative Stress WP408,0.0055518021577841935,7.320143884892087,38.01813858206276,"['GPX3', 'SP1', 'NFKB1', 'TXN2']",0.9538126267173169,0,0,4
2,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.011895306123270723,29.17422434367542,129.288825190523,"['NLRP3', 'NFKB1']",0.9538126267173169,0,0,2
3,16p11.2 proximal deletion syndrome WP4949,0.014935322580646514,3.3848007414272474,14.229791095461401,"['PPP2CA', 'IGFBP3', 'MAZ', 'SIAH1', 'NFKB1', 'BPTF']",0.9538126267173169,0,0,6
4,Ciliary landscape WP4352,0.021443728064467336,2.1599349593495933,8.299167933278142,"['IFT22', 'GDI1', 'NDUFA5', 'VPS4A', 'HTRA2', 'YPEL5', 'AGPAT2', 'EXOC2', 'NFKB1', 'EHBP1', 'ARL8B']",0.9538126267173169,0,0,11
5,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.03635913706684365,9.721559268098648,32.22025859931014,"['AEBP2', 'STK38']",0.9538126267173169,0,0,2
6,Mitochondrial Gene Expression WP391,0.03635913706684365,9.721559268098648,32.22025859931014,"['SP1', 'NRF1']",0.9538126267173169,0,0,2
7,Autophagy WP4923,0.046819334922622,4.380143540669857,13.409629960259972,"['ATG9A', 'AMBRA1', 'WIPI2']",0.9538126267173169,0,0,3
8,Serine Metabolism WP4688,0.06443196977395371,inf,inf,['SHMT2'],0.9538126267173169,0,0,1
9,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.06443196977395371,inf,inf,['SIX4'],0.9538126267173169,0,0,1
10,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.06775115629521196,3.6489234449760763,9.822587202547899,"['PPP3CC', 'SP1', 'NFKB1']",0.9538126267173169,0,0,3
11,Parkinson's disease pathway WP2371,0.06775115629521196,3.6489234449760763,9.822587202547899,"['PRKN', 'ATXN2', 'HTRA2']",0.9538126267173169,0,0,3
12,IL1 and megakaryocytes in obesity WP2865,0.07008471154839184,5.8310262529832935,15.499162851438095,"['NLRP3', 'NFKB1']",0.9538126267173169,0,0,2
13,Folate Metabolism WP176,0.07954924399188831,3.367684946632315,8.524887046150939,"['GPX3', 'SHMT2', 'NFKB1']",0.9538126267173169,0,0,3
14,IL17 signaling pathway WP2112,0.07954924399188831,3.367684946632315,8.524887046150939,"['CEBPD', 'SP1', 'NFKB1']",0.9538126267173169,0,0,3
15,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.08956151040419655,4.858392999204455,11.722474547078344,"['NLRP3', 'NFKB1']",0.9538126267173169,0,0,2
16,Transcriptional cascade regulating adipogenesis WP4211,0.08956151040419655,4.858392999204455,11.722474547078344,"['CEBPD', 'DDIT3']",0.9538126267173169,0,0,2
17,Autosomal recessive Osteopetrosis pathways WP4788,0.12472180343627032,14.552380952380952,30.29324895552466,['NFKB1'],0.9538126267173169,0,0,1
18,Tgif disruption of Shh signaling WP3674,0.12472180343627032,14.552380952380952,30.29324895552466,['FOXG1'],0.9538126267173169,0,0,1
19,MED and Pseudoachondroplasia genes WP4789,0.12472180343627032,14.552380952380952,30.29324895552466,['COL9A3'],0.9538126267173169,0,0,1
20,Nanomaterial-induced inflammasome activation WP3890,0.12472180343627032,14.552380952380952,30.29324895552466,['NFKB1'],0.9538126267173169,0,0,1
21,Sphingolipid Metabolism (general overview) WP4725,0.13232059776040794,3.642601431980907,7.3672616776567486,"['SMPD1', 'CERS1']",0.9538126267173169,0,0,2
22,Sphingolipid Metabolism (integrated pathway) WP4726,0.13232059776040794,3.642601431980907,7.3672616776567486,"['SMPD1', 'CERS1']",0.9538126267173169,0,0,2
23,Sphingolipid pathway WP1422,0.13232059776040794,3.642601431980907,7.3672616776567486,"['PPP2CA', 'GBA2']",0.9538126267173169,0,0,2
24,Monoamine Transport WP727,0.13232059776040794,3.642601431980907,7.3672616776567486,"['AMPH', 'STX1A']",0.9538126267173169,0,0,2
25,Modulators of TCR signaling and T cell activation WP5072,0.13438179256048474,2.573599774838165,5.165395754752352,"['RNF7', 'NFKB1', 'ZFP36L1']",0.9538126267173169,0,0,3
26,Proteasome Degradation WP183,0.13576640223688424,2.1621813660182965,4.317485915663642,"['PSMA5', 'PSMC5', 'PSMB5', 'PSME3']",0.9538126267173169,0,0,4
27,Unfolded protein response WP4925,0.1785910780409665,2.913126491646778,5.018316480653343,"['DDIT3', 'ATF4']",0.9538126267173169,0,0,2
28,Vitamin B12 metabolism WP1533,0.1785910780409665,2.913126491646778,5.018316480653343,"['SHMT2', 'NFKB1']",0.9538126267173169,0,0,2
29,White fat cell differentiation WP4149,0.1785910780409665,2.913126491646778,5.018316480653343,"['CEBPD', 'DDIT3']",0.9538126267173169,0,0,2
30,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.181135094650351,7.275,12.429425868225362,['NFKB1'],0.9538126267173169,0,0,1
31,Disorders of Folate Metabolism and Transport WP4259,0.181135094650351,7.275,12.429425868225362,['SHMT2'],0.9538126267173169,0,0,1
32,LTF danger signal response pathway WP4478,0.181135094650351,7.275,12.429425868225362,['NFKB1'],0.9538126267173169,0,0,1
33,Integrated breast cancer pathway WP1984,0.19454170228032666,1.6966681574239715,2.7776302546285234,"['ATF1', 'GDI1', 'SP1', 'JAKMIP1', 'NFKB1']",0.9538126267173169,0,0,5
34,Energy Metabolism WP1541,0.20254958373418086,2.647862876979822,4.228029500692478,"['PPP3CC', 'NRF1']",0.9538126267173169,0,0,2
35,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.20254958373418086,2.647862876979822,4.228029500692478,"['ILK', 'NFKB1']",0.9538126267173169,0,0,2
36,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.20254958373418086,2.647862876979822,4.228029500692478,"['IFNAR2', 'NFKB1']",0.9538126267173169,0,0,2
37,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.21567251074399713,1.9870595911265767,3.0481378397267465,"['PPP1R15B', 'DDIT3', 'ATF4']",0.9538126267173169,0,0,3
38,Genotoxicity pathway WP4286,0.21567251074399713,1.9870595911265767,3.0481378397267465,"['TIGAR', 'MEX3B', 'CEBPD']",0.9538126267173169,0,0,3
39,Glycosylation and related congenital defects WP4521,0.22683691897943517,2.4268098647573586,3.6002305280211853,"['ALG3', 'MOGS']",0.9538126267173169,0,0,2
40,One-carbon metabolism and related pathways WP3940,0.22683691897943517,2.4268098647573586,3.6002305280211853,"['GPX3', 'SHMT2']",0.9538126267173169,0,0,2
41,Rett syndrome causing genes WP4312,0.22683691897943517,2.4268098647573586,3.6002305280211853,"['FOXG1', 'GPS2']",0.9538126267173169,0,0,2
42,Regulation of toll-like receptor signaling pathway WP1449,0.2270260820071776,1.7150514882211878,2.5428903245953465,"['IFNAR2', 'FBXW5', 'RNF216', 'NFKB1']",0.9538126267173169,0,0,4
43,Serotonin Transporter Activity WP1455,0.23392052843211472,4.849206349206349,7.044800145347369,['STX1A'],0.9538126267173169,0,0,1
44,Supression of HMGB1 mediated inflammation by THBD WP4479,0.23392052843211472,4.849206349206349,7.044800145347369,['NFKB1'],0.9538126267173169,0,0,1
45,Aspirin and miRNAs WP4707,0.23392052843211472,4.849206349206349,7.044800145347369,['NFKB1'],0.9538126267173169,0,0,1
46,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.23392052843211472,4.849206349206349,7.044800145347369,['TOB1'],0.9538126267173169,0,0,1
47,Estrogen Receptor Pathway WP2881,0.23392052843211472,4.849206349206349,7.044800145347369,['SP1'],0.9538126267173169,0,0,1
48,Glutathione metabolism WP100,0.23392052843211472,4.849206349206349,7.044800145347369,['GPX3'],0.9538126267173169,0,0,1
49,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.23392052843211472,4.849206349206349,7.044800145347369,['HIF1AN'],0.9538126267173169,0,0,1
50,"NAD metabolism, sirtuins and aging WP3630",0.23392052843211472,4.849206349206349,7.044800145347369,['NFKB1'],0.9538126267173169,0,0,1
51,NAD+ metabolism WP3644,0.23392052843211472,4.849206349206349,7.044800145347369,['NMNAT3'],0.9538126267173169,0,0,1
52,Riboflavin and CoQ disorders WP5037,0.23392052843211472,4.849206349206349,7.044800145347369,['SLC52A2'],0.9538126267173169,0,0,1
53,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.23392052843211472,4.849206349206349,7.044800145347369,['NFKB1'],0.9538126267173169,0,0,1
54,MECP2 and Associated Rett Syndrome WP3584,0.25064280601525196,1.8208732057416268,2.519590393209788,"['CEBPD', 'SP1', 'FOXG1']",0.9538126267173169,0,0,3
55,Photodynamic therapy-induced unfolded protein response WP3613,0.2513116542848729,2.239765008261428,3.093253131299305,"['DDIT3', 'ATF4']",0.9538126267173169,0,0,2
56,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.2513116542848729,2.239765008261428,3.093253131299305,"['ATF1', 'ATF4']",0.9538126267173169,0,0,2
57,mRNA Processing WP411,0.2555352824389787,1.61923794297895,2.209279808530835,"['PRPF4', 'LSM7', 'SNRPD3', 'PSKH1']",0.9538126267173169,0,0,4
58,TNF-alpha signaling pathway WP231,0.2700547917938609,1.5752155032730573,2.0621625144908324,"['PPP2CA', 'KSR2', 'RFFL', 'NFKB1']",0.9538126267173169,0,0,4
59,Amyotrophic lateral sclerosis (ALS) WP2447,0.2758491421732923,2.079440845550631,2.678114254317086,"['PPP3CC', 'NEFH']",0.9538126267173169,0,0,2
60,Estrogen signaling pathway WP712,0.2758491421732923,2.079440845550631,2.678114254317086,"['SP1', 'NFKB1']",0.9538126267173169,0,0,2
61,Interferon type I signaling pathways WP585,0.2758491421732923,2.079440845550631,2.678114254317086,"['IFNAR2', 'CRKL']",0.9538126267173169,0,0,2
62,Canonical NF-KB pathway WP4562,0.28331088303298896,3.636309523809524,4.58615159871507,['NFKB1'],0.9538126267173169,0,0,1
63,Triacylglyceride synthesis WP325,0.28331088303298896,3.636309523809524,4.58615159871507,['AGPAT2'],0.9538126267173169,0,0,1
64,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.28331088303298896,3.636309523809524,4.58615159871507,['SP1'],0.9538126267173169,0,0,1
65,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.28331088303298896,3.636309523809524,4.58615159871507,['NFKB1'],0.9538126267173169,0,0,1
66,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.28331088303298896,3.636309523809524,4.58615159871507,['NFKB1'],0.9538126267173169,0,0,1
67,Myometrial relaxation and contraction pathways WP289,0.28401255291846955,1.3884107860011474,1.7476438073098326,"['ATF1', 'SP1', 'IGFBP3', 'GNB2', 'NFKB1', 'ATF4']",0.9538126267173169,0,0,6
68,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.3003399500827645,1.9404932378679396,2.3341034275035835,"['TNFSF12', 'NFKB1']",0.9538126267173169,0,0,2
69,Eukaryotic Transcription Initiation WP405,0.32468842465895636,1.8189140811455846,2.0460768962811935,"['ILK', 'POLR2J']",0.9538126267173169,0,0,2
70,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.32468842465895636,1.8189140811455846,2.0460768962811935,"['IFNAR2', 'NFKB1']",0.9538126267173169,0,0,2
71,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.32952403655950585,2.9085714285714284,3.2288225335341583,['NFKB1'],0.9538126267173169,0,0,1
72,Cancer immunotherapy by CTLA4 blockade WP4582,0.32952403655950585,2.9085714285714284,3.2288225335341583,['PPP2CA'],0.9538126267173169,0,0,1
73,Cellular Proteostasis WP4918,0.32952403655950585,2.9085714285714284,3.2288225335341583,['PFDN2'],0.9538126267173169,0,0,1
74,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.32952403655950585,2.9085714285714284,3.2288225335341583,['IFNAR2'],0.9538126267173169,0,0,1
75,Vitamin D in inflammatory diseases WP4482,0.32952403655950585,2.9085714285714284,3.2288225335341583,['NFKB1'],0.9538126267173169,0,0,1
76,Dopamine metabolism WP2436,0.32952403655950585,2.9085714285714284,3.2288225335341583,['PPP2CA'],0.9538126267173169,0,0,1
77,Immune response to tuberculosis WP4197,0.32952403655950585,2.9085714285714284,3.2288225335341583,['IFNAR2'],0.9538126267173169,0,0,1
78,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.32952403655950585,2.9085714285714284,3.2288225335341583,['NFKB1'],0.9538126267173169,0,0,1
79,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.32952403655950585,2.9085714285714284,3.2288225335341583,['NFKB1'],0.9538126267173169,0,0,1
80,Osteoclast Signaling WP12,0.32952403655950585,2.9085714285714284,3.2288225335341583,['AIMP2'],0.9538126267173169,0,0,1
81,Osteopontin Signaling WP1434,0.32952403655950585,2.9085714285714284,3.2288225335341583,['NFKB1'],0.9538126267173169,0,0,1
82,Overview of interferons-mediated signaling pathway WP4558,0.32952403655950585,2.9085714285714284,3.2288225335341583,['IFNAR2'],0.9538126267173169,0,0,1
83,SARS coronavirus and innate immunity WP4912,0.32952403655950585,2.9085714285714284,3.2288225335341583,['IFNAR2'],0.9538126267173169,0,0,1
84,Adipogenesis WP236,0.3442345939161394,1.386547904533516,1.478658909310295,"['CEBPD', 'SP1', 'DDIT3', 'AGPAT2']",0.9538126267173169,0,0,4
85,Male infertility WP4673,0.35855629801103456,1.4552631578947368,1.4926191717155253,"['PACRG', 'ABLIM1', 'DDX4']",0.9538126267173169,0,0,3
86,Glycogen Synthesis and Degradation WP500,0.3726368817370842,1.6162821532749934,1.5955142867559822,"['PPP2CA', 'PPP2R5B']",0.9538126267173169,0,0,2
87,p53 transcriptional gene network WP4963,0.3726368817370842,1.6162821532749934,1.5955142867559822,"['TIGAR', 'POLH']",0.9538126267173169,0,0,2
88,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3726368817370842,1.6162821532749934,1.5955142867559822,"['IGFBP3', 'HIF1AN']",0.9538126267173169,0,0,2
89,Airway smooth muscle cell contraction WP4962,0.3727639169123028,2.4234126984126982,2.3914478613006644,['GDI1'],0.9538126267173169,0,0,1
90,Transcription factor regulation in adipogenesis WP3599,0.3727639169123028,2.4234126984126982,2.3914478613006644,['CEBPD'],0.9538126267173169,0,0,1
91,Tryptophan catabolism leading to NAD+ production WP4210,0.3727639169123028,2.4234126984126982,2.3914478613006644,['NMNAT3'],0.9538126267173169,0,0,1
92,Constitutive Androstane Receptor Pathway WP2875,0.3727639169123028,2.4234126984126982,2.3914478613006644,['SP1'],0.9538126267173169,0,0,1
93,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.3727639169123028,2.4234126984126982,2.3914478613006644,['NFKB1'],0.9538126267173169,0,0,1
94,Nanoparticle triggered autophagic cell death WP2509,0.3727639169123028,2.4234126984126982,2.3914478613006644,['AMBRA1'],0.9538126267173169,0,0,1
95,Phytochemical activity on NRF2 transcriptional activation WP3,0.3727639169123028,2.4234126984126982,2.3914478613006644,['AIMP2'],0.9538126267173169,0,0,1
96,Endoderm differentiation WP2853,0.3741818540904361,1.3230869849574887,1.3006121811481728,"['MBTD1', 'AEBP2', 'NABP2', 'BPTF']",0.9538126267173169,0,0,4
97,Selenium Micronutrient Network WP15,0.37652164578079267,1.4080876678499767,1.3753915079036612,"['GPX3', 'NFKB1', 'SELENOH']",0.9538126267173169,0,0,3
98,22q11.2 copy number variation syndrome WP4657,0.37652164578079267,1.4080876678499767,1.3753915079036612,"['PRKN', 'THAP7', 'CRKL']",0.9538126267173169,0,0,3
99,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.4132213925475639,2.07687074829932,1.8354797377269185,['NRF1'],0.9538126267173169,0,0,1
100,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.4132213925475639,2.07687074829932,1.8354797377269185,['NFKB1'],0.9538126267173169,0,0,1
101,TLR4 Signaling and Tolerance WP3851,0.4132213925475639,2.07687074829932,1.8354797377269185,['NFKB1'],0.9538126267173169,0,0,1
102,Cancer immunotherapy by PD-1 blockade WP4585,0.4132213925475639,2.07687074829932,1.8354797377269185,['NFKB1'],0.9538126267173169,0,0,1
103,Zinc homeostasis WP3529,0.4132213925475639,2.07687074829932,1.8354797377269185,['SLC39A7'],0.9538126267173169,0,0,1
104,Gastric Cancer Network 2 WP2363,0.4132213925475639,2.07687074829932,1.8354797377269185,['COL9A3'],0.9538126267173169,0,0,1
105,Genes controlling nephrogenesis WP4823,0.4132213925475639,2.07687074829932,1.8354797377269185,['ILK'],0.9538126267173169,0,0,1
106,Hippo-Yap signaling pathway WP4537,0.4132213925475639,2.07687074829932,1.8354797377269185,['NF2'],0.9538126267173169,0,0,1
107,miRNAs involvement in the immune response in sepsis WP4329,0.4132213925475639,2.07687074829932,1.8354797377269185,['NFKB1'],0.9538126267173169,0,0,1
108,Pregnane X receptor pathway WP2876,0.4132213925475639,2.07687074829932,1.8354797377269185,['PSMC5'],0.9538126267173169,0,0,1
109,RalA downstream regulated genes WP2290,0.4132213925475639,2.07687074829932,1.8354797377269185,['EXOC2'],0.9538126267173169,0,0,1
110,RAS and bradykinin pathways in COVID-19 WP4969,0.4132213925475639,2.07687074829932,1.8354797377269185,['NFKB1'],0.9538126267173169,0,0,1
111,AGE/RAGE pathway WP2324,0.4191576414907199,1.4541766109785204,1.264418483339474,"['SP1', 'NFKB1']",0.9538126267173169,0,0,2
112,MAPK Signaling Pathway WP382,0.42455688828467086,1.1444390164468328,0.980451514065517,"['CACNB1', 'PPP3CC', 'DDIT3', 'NFKB1', 'CRKL', 'ATF4', 'DUSP7']",0.9538126267173169,0,0,7
113,PI3K-Akt signaling pathway WP4172,0.4247413156541542,1.13025694068972,0.9678107216756504,"['PPP2CA', 'IFNAR2', 'G6PC3', 'GNB2', 'PPP2R5B', 'COL9A3', 'NFKB1', 'ATF4']",0.9538126267173169,0,0,8
114,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.4296671910580165,1.2832113706726709,1.0839855478542395,"['PRKN', 'PSMC5', 'SIAH1']",0.9538126267173169,0,0,3
115,Corticotropin-releasing hormone signaling pathway WP2355,0.44703642259623033,1.246343130553657,1.0034498055170509,"['SP1', 'GNB2', 'NFKB1']",0.9538126267173169,0,0,3
116,EGF/EGFR signaling pathway WP437,0.44798588184781074,1.1542277167277166,0.9268374242249552,"['ATF1', 'ATXN2', 'PLSCR1', 'SP1', 'CRKL']",0.9538126267173169,0,0,5
117,Trans-sulfuration and one-carbon metabolism WP2525,0.45107510667913964,1.8169642857142858,1.4465241866652863,['SHMT2'],0.9538126267173169,0,0,1
118,Type II diabetes mellitus WP1584,0.45107510667913964,1.8169642857142858,1.4465241866652863,['KCNJ11'],0.9538126267173169,0,0,1
119,Gastric Cancer Network 1 WP2361,0.45107510667913964,1.8169642857142858,1.4465241866652863,['RNF216'],0.9538126267173169,0,0,1
120,NRF2-ARE regulation WP4357,0.45107510667913964,1.8169642857142858,1.4465241866652863,['AIMP2'],0.9538126267173169,0,0,1
121,Ovarian infertility WP34,0.45107510667913964,1.8169642857142858,1.4465241866652863,['SMPD1'],0.9538126267173169,0,0,1
122,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.45107510667913964,1.8169642857142858,1.4465241866652863,['NFKB1'],0.9538126267173169,0,0,1
123,Proteoglycan biosynthesis WP4784,0.45107510667913964,1.8169642857142858,1.4465241866652863,['CANT1'],0.9538126267173169,0,0,1
124,Mesodermal commitment pathway WP2857,0.46272446463524236,1.1631654676258993,0.896362656329472,"['MBTD1', 'PPP2CA', 'AEBP2', 'NABP2']",0.9538126267173169,0,0,4
125,Metabolic reprogramming in colon cancer WP4290,0.46386102394878537,1.3215448036450423,1.015171453705349,"['TIGAR', 'SHMT2']",0.9538126267173169,0,0,2
126,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.47710289593677513,1.1401702167677623,0.8437522944689639,"['SP1', 'MAZ', 'SSTR2', 'NFKB1']",0.9538126267173169,0,0,4
127,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.4854426240438148,1.2638788004565735,0.9133978499545872,"['RNF7', 'NFKB1']",0.9538126267173169,0,0,2
128,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.4854426240438148,1.2638788004565735,0.9133978499545872,"['SP1', 'NFKB1']",0.9538126267173169,0,0,2
129,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.4864922584837392,1.614814814814815,1.163529446328286,['ATF1'],0.9538126267173169,0,0,1
130,Apoptosis Modulation by HSP70 WP384,0.4864922584837392,1.614814814814815,1.163529446328286,['NFKB1'],0.9538126267173169,0,0,1
131,Toll-like Receptor Signaling related to MyD88 WP3858,0.4864922584837392,1.614814814814815,1.163529446328286,['NFKB1'],0.9538126267173169,0,0,1
132,Cardiac Progenitor Differentiation WP2406,0.4864922584837392,1.614814814814815,1.163529446328286,['MESP1'],0.9538126267173169,0,0,1
133,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.4864922584837392,1.614814814814815,1.163529446328286,['PPP2CA'],0.9538126267173169,0,0,1
134,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.4864922584837392,1.614814814814815,1.163529446328286,['NFKB1'],0.9538126267173169,0,0,1
135,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.4864922584837392,1.614814814814815,1.163529446328286,['NFKB1'],0.9538126267173169,0,0,1
136,Intraflagellar transport proteins binding to dynein WP4532,0.4864922584837392,1.614814814814815,1.163529446328286,['IFT22'],0.9538126267173169,0,0,1
137,miRNA regulation of p53 pathway in prostate cancer WP3982,0.4864922584837392,1.614814814814815,1.163529446328286,['SIAH1'],0.9538126267173169,0,0,1
138,One-carbon metabolism WP241,0.4864922584837392,1.614814814814815,1.163529446328286,['SHMT2'],0.9538126267173169,0,0,1
139,SARS-CoV-2 mitochondrial interactions WP5038,0.4864922584837392,1.614814814814815,1.163529446328286,['NFKB1'],0.9538126267173169,0,0,1
140,Senescence and Autophagy in Cancer WP615,0.4977710241640257,1.147381012339461,0.800430317973488,"['RSL1D1', 'IGFBP3', 'AMBRA1']",0.9538126267173169,0,0,3
141,The influence of laminopathies on Wnt signaling WP4844,0.5196293345781318,1.453095238095238,0.9512535978087758,['CEBPD'],0.9538126267173169,0,0,1
142,Ebstein-Barr virus LMP1 signaling WP262,0.5196293345781318,1.453095238095238,0.9512535978087758,['NFKB1'],0.9538126267173169,0,0,1
143,Nanomaterial induced apoptosis WP2507,0.5196293345781318,1.453095238095238,0.9512535978087758,['HTRA2'],0.9538126267173169,0,0,1
144,Toll-like Receptor Signaling Pathway WP75,0.5269429809129559,1.1623866348448688,0.7446980294874018,"['IFNAR2', 'NFKB1']",0.9538126267173169,0,0,2
145,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5468282472641957,1.1174958692858454,0.6745434335162862,"['PPP2CA', 'NEFH']",0.9538126267173169,0,0,2
146,DNA IR-damage and cellular response via ATR WP4016,0.5468282472641957,1.1174958692858454,0.6745434335162862,"['SP1', 'PALB2']",0.9538126267173169,0,0,2
147,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.5500712228367096,1.006457167455876,0.6015670105743136,"['PPP2CA', 'IFNAR2', 'TBC1D1', 'GNB2', 'PPP2R5B', 'ITGAE', 'ATF4']",0.9538126267173169,0,0,7
148,Fatty acid beta-oxidation WP143,0.5506327938361404,1.3207792207792208,0.7880919597910441,['CRAT'],0.9538126267173169,0,0,1
149,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.5506327938361404,1.3207792207792208,0.7880919597910441,['NF2'],0.9538126267173169,0,0,1
150,Melatonin metabolism and effects WP3298,0.5506327938361404,1.3207792207792208,0.7880919597910441,['NFKB1'],0.9538126267173169,0,0,1
151,Leptin signaling pathway WP2034,0.5661219199048346,1.075930345620083,0.6121460703666325,"['SP1', 'NFKB1']",0.9538126267173169,0,0,2
152,Signal transduction through IL1R WP4496,0.5796397084252676,1.210515873015873,0.6601530892132804,['NFKB1'],0.9538126267173169,0,0,1
153,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.5796397084252676,1.210515873015873,0.6601530892132804,['DDIT3'],0.9538126267173169,0,0,1
154,Pre-implantation embryo WP3527,0.5796397084252676,1.210515873015873,0.6601530892132804,['DDIT3'],0.9538126267173169,0,0,1
155,Prion disease pathway WP3995,0.5796397084252676,1.210515873015873,0.6601530892132804,['NFKB1'],0.9538126267173169,0,0,1
156,T-cell receptor (TCR) signaling pathway WP69,0.5848175238761133,1.0373337879304467,0.556483317746709,"['NFKB1', 'CRKL']",0.9538126267173169,0,0,2
157,DNA Repair Pathways Full Network WP4946,0.5915336385653567,0.9899412788168769,0.519755529197466,"['ERCC8', 'PALB2', 'POLH']",0.9538126267173169,0,0,3
158,Chemokine signaling pathway WP3929,0.6060237472894326,0.9677830940988835,0.4847007170118103,"['GNB2', 'NFKB1', 'CRKL']",0.9538126267173169,0,0,3
159,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6067783642059125,1.1172161172161172,0.5581518855299927,['CRKL'],0.9538126267173169,0,0,1
160,Target Of Rapamycin (TOR) Signaling WP1471,0.6067783642059125,1.1172161172161172,0.5581518855299927,['RRAGC'],0.9538126267173169,0,0,1
161,Histone Modifications WP2369,0.6067783642059125,1.1172161172161172,0.5581518855299927,['AEBP2'],0.9538126267173169,0,0,1
162,IL-2 signaling pathway WP49,0.6067783642059125,1.1172161172161172,0.5581518855299927,['CRKL'],0.9538126267173169,0,0,1
163,Integrated Cancer Pathway WP1971,0.6067783642059125,1.1172161172161172,0.5581518855299927,['ATF1'],0.9538126267173169,0,0,1
164,Netrin-UNC5B signaling pathway WP4747,0.6067783642059125,1.1172161172161172,0.5581518855299927,['PLEKHH1'],0.9538126267173169,0,0,1
165,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.6067783642059125,1.1172161172161172,0.5581518855299927,['WIPI2'],0.9538126267173169,0,0,1
166,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6067783642059125,1.1172161172161172,0.5581518855299927,['NLRP3'],0.9538126267173169,0,0,1
167,Resistin as a regulator of inflammation WP4481,0.6067783642059125,1.1172161172161172,0.5581518855299927,['NFKB1'],0.9538126267173169,0,0,1
168,B Cell Receptor Signaling Pathway WP23,0.6204046385202183,0.967859984089101,0.46204026190607883,"['NFKB1', 'CRKL']",0.9538126267173169,0,0,2
169,Wnt signaling pathway and pluripotency WP399,0.6204046385202183,0.967859984089101,0.46204026190607883,"['PPP2CA', 'ESRRB']",0.9538126267173169,0,0,2
170,Ras signaling WP4223,0.62300885828808,0.9361800881875145,0.4429953076239057,"['GNB2', 'KSR2', 'NFKB1', 'EXOC2']",0.9538126267173169,0,0,4
171,Copper homeostasis WP3286,0.6321688224700609,1.0372448979591837,0.475679261719175,['SP1'],0.9538126267173169,0,0,1
172,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6321688224700609,1.0372448979591837,0.475679261719175,['LRSAM1'],0.9538126267173169,0,0,1
173,miRNA regulation of prostate cancer signaling pathways WP3981,0.6321688224700609,1.0372448979591837,0.475679261719175,['NFKB1'],0.9538126267173169,0,0,1
174,Nuclear receptors WP170,0.6321688224700609,1.0372448979591837,0.475679261719175,['ESRRB'],0.9538126267173169,0,0,1
175,Oxidative Damage WP3941,0.6321688224700609,1.0372448979591837,0.475679261719175,['NFKB1'],0.9538126267173169,0,0,1
176,Ectoderm Differentiation WP2858,0.6474118696170011,0.9068480861244019,0.39427270326693714,"['TRPM2', 'NF2', 'JAKMIP1']",0.9538126267173169,0,0,3
177,Nonalcoholic fatty liver disease WP4396,0.6480718804680146,0.9064002403846154,0.3931544236256,"['NDUFA5', 'DDIT3', 'COX7A1', 'NFKB1', 'ATF4']",0.9538126267173169,0,0,5
178,Integrin-mediated Cell Adhesion WP185,0.6535965779037727,0.9070704057279236,0.38574526998221964,"['ILK', 'ITGAE']",0.9538126267173169,0,0,2
179,Prolactin Signaling Pathway WP2037,0.6535965779037727,0.9070704057279236,0.38574526998221964,"['CTSD', 'NFKB1']",0.9538126267173169,0,0,2
180,Splicing factor NOVA regulated synaptic proteins WP4148,0.6559234463083948,0.967936507936508,0.4081896610088846,['KCNMA1'],0.9538126267173169,0,0,1
181,Endothelin Pathways WP2197,0.6559234463083948,0.967936507936508,0.4081896610088846,['RIIAD1'],0.9538126267173169,0,0,1
182,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6559234463083948,0.967936507936508,0.4081896610088846,['NFKB1'],0.9538126267173169,0,0,1
183,Neovascularisation processes WP4331,0.6559234463083948,0.967936507936508,0.4081896610088846,['NFKB1'],0.9538126267173169,0,0,1
184,Nephrotic syndrome WP4758,0.6559234463083948,0.967936507936508,0.4081896610088846,['TTC21B'],0.9538126267173169,0,0,1
185,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6559234463083948,0.967936507936508,0.4081896610088846,['NFKB1'],0.9538126267173169,0,0,1
186,G Protein Signaling Pathways WP35,0.6693065188373871,0.8794387792001157,0.3531062337116294,"['PPP3CC', 'GNB2']",0.9538126267173169,0,0,2
187,ATM Signaling Network in Development and Disease  WP3878,0.6781473928916885,0.9072916666666667,0.3523835738654396,['NFKB1'],0.9538126267173169,0,0,1
188,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6781473928916885,0.9072916666666667,0.3523835738654396,['NFKB1'],0.9538126267173169,0,0,1
189,Development of ureteric collection system WP5053,0.6781473928916885,0.9072916666666667,0.3523835738654396,['ILK'],0.9538126267173169,0,0,1
190,Disruption of postsynaptic signaling by CNV WP4875,0.6781473928916885,0.9072916666666667,0.3523835738654396,['STX1A'],0.9538126267173169,0,0,1
191,Notch Signaling Pathway Netpath WP61,0.6781473928916885,0.9072916666666667,0.3523835738654396,['NFKB1'],0.9538126267173169,0,0,1
192,p38 MAPK Signaling Pathway WP400,0.6781473928916885,0.9072916666666667,0.3523835738654396,['DDIT3'],0.9538126267173169,0,0,1
193,TGF-beta Receptor Signaling WP560,0.6989390745527123,0.853781512605042,0.30581745263739885,['NFKB1'],0.9538126267173169,0,0,1
194,Vitamin A and carotenoid metabolism WP716,0.6989390745527123,0.853781512605042,0.30581745263739885,['BCO2'],0.9538126267173169,0,0,1
195,Interleukin-11 Signaling Pathway WP2332,0.6989390745527123,0.853781512605042,0.30581745263739885,['ATF1'],0.9538126267173169,0,0,1
196,Metapathway biotransformation Phase I and II WP702,0.709333396466024,0.8206193012548524,0.28182498151209606,"['GPX3', 'KCNAB3', 'NAA80']",0.9538126267173169,0,0,3
197,Peptide GPCRs WP24,0.7183905906676429,0.8062169312169312,0.2666496871546636,['SSTR2'],0.9538126267173169,0,0,1
198,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7206630836457841,0.8052897395002658,0.26379966462018484,"['PPP2CA', 'DOCK3', 'NFKB1']",0.9538126267173169,0,0,3
199,Hippo-Merlin Signaling Dysregulation WP4541,0.7264403909318999,0.7838482874282396,0.25051701044049196,"['NF2', 'ITGAE']",0.9538126267173169,0,0,2
200,3q29 copy number variation syndrome WP4906,0.736588131329803,0.7636591478696741,0.23347075284678442,['NF2'],0.9538126267173169,0,0,1
201,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.736588131329803,0.7636591478696741,0.23347075284678442,['NFKB1'],0.9538126267173169,0,0,1
202,Aryl Hydrocarbon Receptor Netpath WP2586,0.736588131329803,0.7636591478696741,0.23347075284678442,['NFKB1'],0.9538126267173169,0,0,1
203,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.736588131329803,0.7636591478696741,0.23347075284678442,['NFKB1'],0.9538126267173169,0,0,1
204,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.736588131329803,0.7636591478696741,0.23347075284678442,['NFKB1'],0.9538126267173169,0,0,1
205,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.736588131329803,0.7636591478696741,0.23347075284678442,['CEBPD'],0.9538126267173169,0,0,1
206,PDGF Pathway WP2526,0.736588131329803,0.7636591478696741,0.23347075284678442,['NFKB1'],0.9538126267173169,0,0,1
207,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.736588131329803,0.7636591478696741,0.23347075284678442,['ILK'],0.9538126267173169,0,0,1
208,Apoptosis Modulation and Signaling WP1772,0.7517413411915908,0.7434061562939844,0.21214059267727894,"['HTRA2', 'NFKB1']",0.9538126267173169,0,0,2
209,IL-3 signaling pathway WP286,0.7536123561092022,0.7253571428571428,0.20518696837106076,['CRKL'],0.9538126267173169,0,0,1
210,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7536123561092022,0.7253571428571428,0.20518696837106076,['NFKB1'],0.9538126267173169,0,0,1
211,Kit receptor signaling pathway WP304,0.7536123561092022,0.7253571428571428,0.20518696837106076,['CRKL'],0.9538126267173169,0,0,1
212,MET in type 1 papillary renal cell carcinoma WP4205,0.7536123561092022,0.7253571428571428,0.20518696837106076,['CRKL'],0.9538126267173169,0,0,1
213,Cytosolic DNA-sensing pathway WP4655,0.7695387476792317,0.690702947845805,0.18093928811248247,['NFKB1'],0.9538126267173169,0,0,1
214,IL-1 signaling pathway WP195,0.7695387476792317,0.690702947845805,0.18093928811248247,['NFKB1'],0.9538126267173169,0,0,1
215,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7844379437589182,0.6591991341991342,0.16004551603028389,['NABP2'],0.9538126267173169,0,0,1
216,IL-4 signaling pathway WP395,0.7844379437589182,0.6591991341991342,0.16004551603028389,['NFKB1'],0.9538126267173169,0,0,1
217,Nucleotide Excision Repair WP4753,0.7844379437589182,0.6591991341991342,0.16004551603028389,['ERCC8'],0.9538126267173169,0,0,1
218,Pathogenic Escherichia coli infection WP2272,0.7844379437589182,0.6591991341991342,0.16004551603028389,['ARPC4'],0.9538126267173169,0,0,1
219,PPAR signaling pathway WP3942,0.7844379437589182,0.6591991341991342,0.16004551603028389,['ILK'],0.9538126267173169,0,0,1
220,RANKL/RANK signaling pathway WP2018,0.7844379437589182,0.6591991341991342,0.16004551603028389,['NFKB1'],0.9538126267173169,0,0,1
221,IL-18 signaling pathway WP4754,0.7885972456289011,0.7533303285256411,0.1789156142371713,"['STOML1', 'SP1', 'LRRFIP1', 'RND2', 'NFKB1']",0.9538126267173169,0,0,5
222,NRF2 pathway WP2884,0.7963413614733686,0.6738080701559638,0.15344451880921825,"['GPX3', 'SLC39A7']",0.9538126267173169,0,0,2
223,Neural Crest Differentiation WP2064,0.798376046986271,0.6304347826086957,0.14195850250944106,['NFKB1'],0.9538126267173169,0,0,1
224,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.798376046986271,0.6304347826086957,0.14195850250944106,['NFKB1'],0.9538126267173169,0,0,1
225,Regulatory circuits of the STAT3 signaling pathway WP4538,0.798376046986271,0.6304347826086957,0.14195850250944106,['IFNAR2'],0.9538126267173169,0,0,1
226,Circadian rhythm related genes WP3594,0.8157154789857037,0.6783418062200957,0.1381712135915643,"['KCNMA1', 'FBXL3', 'ATF4']",0.9538126267173169,0,0,3
227,Ebola Virus Pathway on Host WP4217,0.8158710925598063,0.6436488994961549,0.13098185030789072,"['VPS4A', 'NFKB1']",0.9538126267173169,0,0,2
228,Cardiac Hypertrophic Response WP2795,0.8236124360438256,0.5798095238095238,0.11251505561324626,['NFKB1'],0.9538126267173169,0,0,1
229,"GPCRs, Other WP117",0.8236124360438256,0.5798095238095238,0.11251505561324626,['SSTR2'],0.9538126267173169,0,0,1
230,Head and Neck Squamous Cell Carcinoma WP4674,0.8236124360438256,0.5798095238095238,0.11251505561324626,['NFKB1'],0.9538126267173169,0,0,1
231,Joubert Syndrome WP4656,0.8236124360438256,0.5798095238095238,0.11251505561324626,['ATF4'],0.9538126267173169,0,0,1
232,Mitochondrial CIV Assembly WP4922,0.8236124360438256,0.5798095238095238,0.11251505561324626,['PET117'],0.9538126267173169,0,0,1
233,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8236124360438256,0.5798095238095238,0.11251505561324626,['NFKB1'],0.9538126267173169,0,0,1
234,Vitamin D Receptor Pathway WP2877,0.8249948732367616,0.6295527653834181,0.12111216921400889,"['SATB1', 'IGFBP3']",0.9538126267173169,0,0,2
235,Calcium Regulation in the Cardiac Cell WP536,0.8310405736083984,0.657568508046977,0.12170058337358579,"['CACNB1', 'GJC2', 'GNB2']",0.9538126267173169,0,0,3
236,7q11.23 copy number variation syndrome WP4932,0.8337108329297845,0.6160564667648403,0.11204136400338266,"['STX1A', 'ATF4']",0.9538126267173169,0,0,2
237,Pyrimidine metabolism WP4022,0.8337108329297845,0.6160564667648403,0.11204136400338266,"['DTYMK', 'POLR2J']",0.9538126267173169,0,0,2
238,Synaptic Vesicle Pathway WP2267,0.8350227757708378,0.5574175824175824,0.10050031547467796,['STX1A'],0.9538126267173169,0,0,1
239,Oncostatin M Signaling Pathway WP2374,0.8350227757708378,0.5574175824175824,0.10050031547467796,['NFKB1'],0.9538126267173169,0,0,1
240,Gastrin signaling pathway WP4659,0.8420334980170114,0.6031225139220366,0.10369815993297442,"['SP1', 'NFKB1']",0.9540296617258494,0,0,2
241,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8456966232148555,0.5366843033509701,0.08994538314423461,['CACNB1'],0.9540296617258494,0,0,1
242,Genes related to primary cilium development (based on CRISPR) WP4536,0.8456966232148555,0.5366843033509701,0.08994538314423461,['TTC21B'],0.9540296617258494,0,0,1
243,Acute viral myocarditis WP4298,0.855681410051142,0.5174319727891157,0.08064547603247008,['ILK'],0.9555625577567758,0,0,1
244,Amino Acid metabolism WP3925,0.855681410051142,0.5174319727891157,0.08064547603247008,['AUH'],0.9555625577567758,0,0,1
245,"GPCRs, Class A Rhodopsin-like WP455",0.8575561415765937,0.5788066825775656,0.08894443044364227,"['GPR27', 'SSTR2']",0.9555625577567758,0,0,2
246,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.873758484479217,0.48277777777777775,0.06515147668249667,['SP1'],0.9579761697302259,0,0,1
247,Endometrial cancer WP4155,0.873758484479217,0.48277777777777775,0.06515147668249667,['ILK'],0.9579761697302259,0,0,1
248,Exercise-induced Circadian Regulation WP410,0.873758484479217,0.48277777777777775,0.06515147668249667,['TOB1'],0.9579761697302259,0,0,1
249,Melanoma WP4685,0.873758484479217,0.48277777777777775,0.06515147668249667,['PREX2'],0.9579761697302259,0,0,1
250,Nuclear Receptors Meta-Pathway WP2882,0.8799568317573638,0.6209226167453135,0.07940509154033393,"['PSMC5', 'SP1', 'GPX3', 'SLC39A7']",0.9592319048743947,0,0,4
251,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8819311652874472,0.46712749615975424,0.058690491828657,['EXOC2'],0.9592319048743947,0,0,1
252,Apoptosis WP254,0.8895759257789446,0.4524553571428571,0.05294199033043383,['NFKB1'],0.9634080412192393,0,0,1
253,Hepatitis B infection WP4666,0.8961268126873075,0.5162802591203546,0.05662218246141111,"['NFKB1', 'ATF4']",0.9634080412192393,0,0,2
254,Wnt signaling WP428,0.903415599092034,0.4257002801120448,0.04323947951130115,['PPP3CC'],0.9634080412192393,0,0,1
255,ErbB signaling pathway WP673,0.903415599092034,0.4257002801120448,0.04323947951130115,['CRKL'],0.9634080412192393,0,0,1
256,Mitochondrial complex I assembly model OXPHOS system WP4324,0.903415599092034,0.4257002801120448,0.04323947951130115,['NDUFA5'],0.9634080412192393,0,0,1
257,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9096721387803754,0.41346938775510206,0.039143573409604004,['NFKB1'],0.9646958170835206,0,0,1
258,Androgen receptor signaling pathway WP138,0.9209981136456958,0.390990990990991,0.03217749932008746,['SP1'],0.9646958170835206,0,0,1
259,Ciliopathies WP4803,0.9248001476401657,0.46585572407421666,0.036419492432328754,"['TTC21B', 'LRRC6']",0.9646958170835206,0,0,2
260,Alzheimer's disease WP2059,0.9261180305374808,0.3806390977443609,0.02921541712260578,['PPP3CC'],0.9646958170835206,0,0,1
261,Pathways Regulating Hippo Signaling WP4540,0.9261180305374808,0.3806390977443609,0.02921541712260578,['NF2'],0.9646958170835206,0,0,1
262,Pancreatic adenocarcinoma pathway WP4263,0.9309068657077987,0.37081807081807083,0.026549106744753755,['NFKB1'],0.9646958170835206,0,0,1
263,Small cell lung cancer WP4658,0.9395753629245406,0.3526132404181185,0.02197741265572534,['NFKB1'],0.9646958170835206,0,0,1
264,TGF-beta Signaling Pathway WP366,0.9395753629245406,0.3526132404181185,0.02197741265572534,['SP1'],0.9646958170835206,0,0,1
265,Oxidative phosphorylation WP623,0.9395753629245406,0.3526132404181185,0.02197741265572534,['NDUFA5'],0.9646958170835206,0,0,1
266,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9428221107915004,0.4307341573754141,0.025360617517118246,"['NDUFA5', 'COX7A1']",0.9646958170835206,0,0,2
267,DNA damage response (only ATM dependent) WP710,0.9434937112135531,0.3441609977324263,0.020018323900625624,['NFKB1'],0.9646958170835206,0,0,1
268,Pathways in clear cell renal cell carcinoma WP4018,0.953791947424064,0.32105820105820104,0.015189172240539891,['SHMT2'],0.9682161723235945,0,0,1
269,Focal Adhesion WP306,0.9542043843538485,0.40619852768160275,0.019041527252550892,"['ILK', 'CRKL']",0.9682161723235945,0,0,2
270,VEGFA-VEGFR2 Signaling Pathway WP3888,0.9576316720717587,0.567046043833074,0.0245485861683564,"['PPP2CA', 'ARMCX1', 'IGFBP3', 'TRIP4', 'NFKB1', 'RND1', 'ATF4']",0.9682161723235945,0,0,7
271,Cell cycle WP179,0.9622168916494582,0.30084325396825395,0.011587096649396085,['ANAPC13'],0.9682161723235945,0,0,1
272,Fragile X Syndrome  WP4549,0.9646695929377938,0.29465500485908647,0.010598630621493736,['PPP2R5B'],0.9682161723235945,0,0,1
273,Breast cancer pathway WP4262,0.9747456641739873,0.26715167548500884,0.006833392366951077,['SP1'],0.9747456641739873,0,0,1
